tirzepatide does | GLP1 | Medical Weight Loss The promise of tirzepatide: A

The thymus has the function of producing autoantibodies in MG pathology, so it is reasonable to suspect that patients with seronegative pathology may have low-affinity antibodies, but other hypotheses cannot be ruled out due to its heterogeneity (Mergenthaler et al., 2022)

By activating both the GLP-1 and GIP receptors, tirzepatide: Slows down digestion Regulates the release of insulin and glucagon Sends satiety (fullness) signals to your brain Together, these effects balance blood sugar levels and reduce appetite, which can lead to weight loss in people with type 2 diabetes and obesity

Dont forget to check the expiry date on your Ozempic pen

Giving patients a simple daily oral option instead of a shot means fewer barriers to staying on track